QIAGEN
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
QGEN Key Statistics
Stock Snapshot
The current QIAGEN(QGEN) stock price is $51.06, with a market capitalization of 10.59B. The stock trades at a price-to-earnings (P/E) ratio of 25.00 and offers a dividend yield of 51.5%.
As of 2026-02-11, QIAGEN(QGEN) stock has fluctuated between $50.77 and $51.32. The current price stands at $51.06, placing the stock +0.6% above today's low and -0.5% off the high.
The QIAGEN(QGEN)'s current trading volume is 1.47M, compared to an average daily volume of 2.77M.
In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $37.63.
In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $37.63.
QGEN News
Qiagen ( (QGEN) ) has issued an update. QIAGEN disclosed that the Netherlands Authority for the Financial Markets has notified the company of a substantial sha...
Qiagen (NYSE:QGEN) has launched new automation platforms for DNA and RNA extraction in clinical laboratories. The line up includes sustainability focused consu...
UBS raised the firm’s price target on Qiagen (QGEN) to $52 from $50 and keeps a Neutral rating on the shares. Qiagen’s portfolio holds several attractive growth...
Analyst ratings
67%
of 24 ratingsMore QGEN News
Advertisement What Qiagen (QGEN) offers and how the business makes money Qiagen (QGEN) focuses on what it calls sample to insight solutions, essentially turni...
Qiagen ((QGEN)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powe...
Qiagen ( (QGEN) ) just unveiled an announcement. On February 4, 2026, Qiagen reported unaudited results for the fourth quarter and full year ended December 31,...
Qiagen (NYSE:QGEN) introduced new laboratory automation platforms at SLAS 2026, including the public debut of its QIAsprint Connect system. The company highlig...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.